A second chance for success with BRAF and MEK inhibitors in melanoma.

Authors	Kelly G Paulson, John A Thompson
Journal	The Lancet. Oncology (Lancet Oncol) Vol. 18 Issue 4 Pg. 418-419 (04 2017) ISSN: 1474-5488 [Electronic] England
PMID	28268065 (Publication Type: Journal Article, Comment)
Chemical References	Protein Kinase Inhibitors BRAF protein, human Proto-Oncogene Proteins B-raf
Topics	Cell Line, Tumor Humans Melanoma Protein Kinase Inhibitors Proto-Oncogene Proteins B-raf

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!